| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 01/16/2013 | CN102872276A Oil solution medicine for treating atrophic beriberi |
| 01/16/2013 | CN102872274A Traditional Chinese medicine composition for treating pedopathy |
| 01/16/2013 | CN102872265A American ginseng and fleece-flower root humagsolan tablet group |
| 01/16/2013 | CN102872260A Method for treating and/or preventing inflammation and cutaneous photodamage by using water soluble extract from plant of Solanum genus and having photoprotective effect |
| 01/16/2013 | CN102872250A Lotion for treating eczema |
| 01/16/2013 | CN102872248A Traditional Chinese medicine for treating beriberi and tinea manus and pedis |
| 01/16/2013 | CN102872244A Burn and scald treatment medicament and preparation method thereof |
| 01/16/2013 | CN102872241A Traditional Chinese medicinal composition for treating inflammatory dermatosis and preparation thereof |
| 01/16/2013 | CN102872235A Decoction medicament for treating qi and blood disharmony type vitiligo |
| 01/16/2013 | CN102872222A Chinese medicinal decoction for treating blood deficiency and wind dryness type alopecia areata |
| 01/16/2013 | CN102872218A Chinese herba preparation for treating acute radiation skin injury |
| 01/16/2013 | CN102872210A Traditional Chinese medicine for treating urticaria |
| 01/16/2013 | CN102872202A Ointment for nursing private parts of middle and old aged women and preparation method thereof |
| 01/16/2013 | CN102872200A Externally-applied medicine for treating alopecia areata |
| 01/16/2013 | CN102872199A Externally used paste for treating burn |
| 01/16/2013 | CN102872196A Tincture medicament for treating wet beriberi |
| 01/16/2013 | CN102872193A Oral Chinese medicament for treating meridian blocking leucoderma |
| 01/16/2013 | CN102872192A Swelling dispersing and itching relieving cream |
| 01/16/2013 | CN102872187A External carbuncle cream and preparation method thereof |
| 01/16/2013 | CN102872171A Method for preparing radix isatidis injection |
| 01/16/2013 | CN102872166A Method for preparing tyrosinase inhibitor from pine needles |
| 01/16/2013 | CN102872160A Nano-silver foaming agent used for sterilizing wounds of scalds and burns and ulcer wounds |
| 01/16/2013 | CN102872158A External drug combination for curing eczema and preparation method thereof |
| 01/16/2013 | CN102872089A Application of Houttuynoid E in medicines for treating skin cancer |
| 01/16/2013 | CN102872086A Application of Houttuynoid A in medicines for treating skin cancer |
| 01/16/2013 | CN102872063A Application of dammarane sapogenin compound |
| 01/16/2013 | CN102872012A Compound capable of inhibiting protein kinase and application thereof |
| 01/16/2013 | CN102871989A External preparation containing either honokiol or pharmaceutically acceptable salt of honokiol and new application |
| 01/16/2013 | CN102871955A Ointment medicament composition containing mupirocin |
| 01/16/2013 | CN102871936A Nano-carrier loaded with rhodiola rosea extract and preparation method and application thereof |
| 01/16/2013 | CN102871926A Bath foam with heat clearing and detoxicating functions |
| 01/16/2013 | CN102871906A Hand cream for promoting wound healing |
| 01/16/2013 | CN102871860A Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity |
| 01/16/2013 | CN102871857A Synthesis of a nitroxide antioxidant and methods of use in cosmetic and dermatological compositions |
| 01/16/2013 | CN102871015A Pollen health care product and preparation method of pollen health care product |
| 01/16/2013 | CN102327567B Preparation method for Chinese medicinal lotion for treating engorgement bedsore |
| 01/16/2013 | CN102247444B Medicine for treating burn and scald and preparation method thereof |
| 01/16/2013 | CN101564049B Pure natural mosquito-repellent perfume and preparation method thereof |
| 01/16/2013 | CN101380288B Use of a Bifidobacterium species lysate for treating sensitive skin |
| 01/15/2013 | US8354397 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 01/15/2013 | CA2558254C Cream-gel containing ivermectin |
| 01/15/2013 | CA2483817C Novel ligands that are inhibitors of the rar receptors, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/15/2013 | CA2430133C Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 01/10/2013 | WO2013006729A2 Cannabinoid receptor binding agents, compositions and methods |
| 01/10/2013 | WO2013005698A1 Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 01/10/2013 | WO2013005514A1 Skin-improving agent for oral intake |
| 01/10/2013 | WO2013005281A1 Platelet-derived growth factor-bb production promoter, and mesenchymal stem cell production promoter, stem cell stabilizer and dermis regenerator each comprising same |
| 01/10/2013 | WO2013004984A1 Tricyclic compounds for use as kinase inhibitors |
| 01/10/2013 | WO2013004777A1 Photoprotective composition |
| 01/10/2013 | WO2013004683A1 Hemostatic agent particularly for use in surgical procedures |
| 01/10/2013 | WO2013004422A1 Topical compositions for use in the prevention and/or treatment of dermatitis |
| 01/10/2013 | WO2013004205A1 Process for the preparation of a pharmaceutically effective extract from arthrospira spec. |
| 01/10/2013 | WO2012121988A3 Methods for treating diseases using isoindoline compounds |
| 01/10/2013 | WO2012061698A9 Compounds useful as modulators of trpm8 |
| 01/10/2013 | WO2011117377A3 Compositions comprising brimonidine for the treatment of erythema |
| 01/10/2013 | US20130012692 Sodium channel blockers |
| 01/10/2013 | US20130012588 Compositions and methods for prevention and treatement of wounds |
| 01/10/2013 | US20130012583 Vinyl substituted fatty acids |
| 01/10/2013 | US20130012582 Vinylic mask with peel-off effect for topical use containing high concentrations of retinoic acid |
| 01/10/2013 | US20130012577 Process to obtain a standardized extract of quercetin and 3-o-methylquercetin from inflorescences of macela-do-campo, a cosmetic, pharmaceutical and veterinary composition containing extract of macela-do-campo, the use of this extract and the method of application of the aforesaid extract |
| 01/10/2013 | US20130012575 Plant extract from low-thc cannabis for the treatment of disease |
| 01/10/2013 | US20130012567 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/10/2013 | US20130012566 Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia |
| 01/10/2013 | US20130012564 SMAC Mimetic |
| 01/10/2013 | US20130012545 Amido-Thiophene Compounds and Their Use |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012517 Quinoline and Quinoxaline Derivatives as Kinase Inhibitors |
| 01/10/2013 | US20130012510 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1 |
| 01/10/2013 | US20130012507 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 01/10/2013 | US20130012505 Benzonaphthyridinamines as autotaxin inhibitors |
| 01/10/2013 | US20130012494 Cyclopropyl-fused-1,3-thiazepines as bace1 and/or bace2 inhibitors |
| 01/10/2013 | US20130012490 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 01/10/2013 | US20130012487 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors |
| 01/10/2013 | US20130012484 Petroleum jelly-free unguent compositions comprising vitamin d compounds and optionally steroidal anti-inflammatory agents |
| 01/10/2013 | US20130012480 Crystalline salts of (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide and methods of using the same |
| 01/10/2013 | US20130012475 Cosmetic and Pharmaceutical Composition Comprising N-Acetylglucosamine-6-Phosphate |
| 01/10/2013 | US20130012466 Colchicine neoglycosides and methods for their synthesis and use |
| 01/10/2013 | US20130012460 Topical pharmaceutical formulations containing a low concentration of benzoyl peroxide in suspension in water and a water-miscible organic solvent |
| 01/10/2013 | US20130012453 Acceleration Of Wound Healing By A Tissue Inhibitor Of Metalloproteinases (TIMP) Linked To Glycosylphosphatidylinositol (GPI)-Anchors |
| 01/10/2013 | US20130012449 Solvent-free process for obtaining phospholipids and neutral enriched krill oils |
| 01/10/2013 | US20130011902 Stimulation of the synthesis of the activity of an isoform of lysyl oxidase-like loxl for stimulating the formation of elastic fibers |
| 01/10/2013 | US20130011494 Composition for treating decubitus ulcers in diabetic and non-diabetic patients |
| 01/10/2013 | US20130011487 Fluorinated block co-polymers |
| 01/10/2013 | US20130011484 Cannabinoid Receptor Binding Agents, Compositions, and Methods |
| 01/10/2013 | US20130011453 Buffered microencapsulated compositions and methods |
| 01/10/2013 | US20130011452 Topical foam composition |
| 01/10/2013 | US20130011405 Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 01/10/2013 | US20130011391 Anti-psgl-1 antibodies and uses thereof |
| 01/10/2013 | US20130011361 Pyrazole derivatives which modulate stearoyl-coa desaturase |
| 01/10/2013 | US20130011349 Topical Formulations Containing Palm Pollen |
| 01/10/2013 | US20130011342 Surfactant-free, water-free formable composition and breakable foams and their uses |
| 01/10/2013 | CA2840918A1 Topical compositions for use in the prevention and/or treatment of dermatitis |
| 01/10/2013 | CA2840907A1 Cannabinoid receptor binding agents, compositions and methods |
| 01/10/2013 | CA2839678A1 Process for the preparation of a pharmaceutically effective extract from arthrospira spec. |
| 01/10/2013 | CA2839453A1 Methods and compositions useful for treating fitzpatrick type iv, v or vi skin |
| 01/09/2013 | EP2543670A1 Pyrazolopyrimidine derivative |
| 01/09/2013 | EP2543378A1 Anticonnexin polynucleotides as impaired wound healing compositions |
| 01/09/2013 | EP2543377A1 Anticonnexin polynucleotides as impaired wound healing compositions |
| 01/09/2013 | EP2543371A1 Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis |
| 01/09/2013 | EP2543369A2 Solution for peritoneal dialysis |